ruxolitinib

Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Incyte
ruxolitinib
clinical trials
pediatric
atopic dermatitis
Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion
Endpoints
Fri, 03/24/23 - 10:05 am
Incyte
FDA
ruxolitinib
CRL
Incyte on a Roll with Two FDA Wins in Two Days
BioSpace
Thu, 09/23/21 - 10:55 pm
Incyte
FDA
Jakafi
graft vs host disease
ruxolitinib
atopic dermatitis
Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning
Endpoints
Wed, 09/22/21 - 11:17 am
FDA
Incyte
atopic dermatitis
ruxolitinib
Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream
Fierce Pharma
Sat, 06/12/21 - 10:23 pm
Incyte
atopic dermatitis
ruxolitinib
FDA
Incyte’s Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials Published: May 17, 2021 By Brandon May
BioSpace
Mon, 05/17/21 - 11:02 pm
Incyte
ruxolitinib
vitiligo
clinical trials
Incyte Says FDA Grants Priority Review For Eczema Cream
Yahoo/SmarterAnalyst
Mon, 02/22/21 - 11:00 am
Incyte
eczema
FDA
priority review
ruxolitinib
Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis
Endpoints
Thu, 07/23/20 - 11:06 am
ruxolitinib
Novartis
Incyte
graft vs host disease
Incyte hits endpoint in 2nd pivotal atopic dermatitis trial
Fierce Biotech
Wed, 02/19/20 - 09:58 am
Incyte
ruxolitinib
clinical trials
atopic dermatitis
Incyte's skin disease drug meets main goal in late-stage study
Yahoo/Reuters
Tue, 01/28/20 - 12:00 pm
Incyte
clinical trials
atopic dermatitis
ruxolitinib
Incyte announces first patient treated in phase 3 trial program evaluating Ruxolitinib cream in patients with vitiligo
Pharmaceutical Business Review
Thu, 09/26/19 - 07:42 pm
Incyte
clinical trials
ruxolitinib
vitiligo
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
$35M deal: Incyte licenses Lilly drug for potential new use
Bizjournals.com
Wed, 04/6/16 - 10:20 pm
Incyte
Eli Lilly
ruxolitinib
graft vs host disease
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
A Bad Day for Biotech as Celgene, Incyte Tumble
Barron's
Thu, 01/28/16 - 09:30 pm
Celgene
Incyte
ruxolitinib
Vertex Pharmaceuticals
5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Mon, 12/1/14 - 04:45 pm
biotech
Incyte
ruxolitinib
Cubist Pharma
ceftolozane/tazobactam
Biocryst
peramivir
Vertex Pharmaceuticals
Kalydeco
Pozen
PA8140/PA32540
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Incyte discloses patient treated with ruxolitinib develops PML
The Fly on the Wall
Mon, 03/18/13 - 10:56 am
Incyte
PML
ruxolitinib
Jakafi
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol
The Big Bet on YM BioSciences
Motley Fool
Thu, 09/1/11 - 12:14 pm
YM BioSciences
myelofibrosis
ruxolitinib
CYT387
Novartis
Incyte

Pages